• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非对药物不良事件及报告的认知与态度

Awareness and Attitudes Regarding Adverse Drug Events and Reporting in South Africa.

作者信息

Ncube Nokukhanya, Lubbe Martha S, Steyn Hanlie, Motaze Nkengafac V

机构信息

Medicine Usage in South Africa, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.

出版信息

Ther Innov Regul Sci. 2025 May 13. doi: 10.1007/s43441-025-00795-x.

DOI:10.1007/s43441-025-00795-x
PMID:40360900
Abstract

BACKGROUND

Reporting of adverse drug events (ADEs), by consumers enhances medication-related risk surveillance, public awareness, and understanding of medicine safety. The aim of this study was to explore adults' awareness of ADEs, attitudes towards reporting and perceptions of their role in reporting ADEs in South Africa.

METHOD

We conducted a cross-sectional, analytical study in which adults residing in South Africa completed an online questionnaire. The data collected was analysed using both descriptive and inferential statistics.

RESULTS

We received responses from 350 participants. Most participants (86.2%, n = 302; N = 350) reported having heard about ADEs and the majority of participants (94.4%, n = 301; N = 319) indicated that reporting of ADEs was important. The Med Safety App was not widely known (17.3%, n = 58; N = 336) while the South African Health Products Regulatory Authority (SAHPRA) was relatively well known (77.4%, n = 260; N = 336). Healthcare providers only educated 55.7% (n = 180; N = 323) of the participants about ADEs and only 50.5% (n = 163; N = 323) of the participants asked their healthcare providers about ADEs. Awareness regarding ADEs was significantly higher (p < 0.001) among healthcare professionals (HCPs) compared to non-healthcare professionals (non-HCP).

CONCLUSION

Most participants were aware of ADEs and agreed it was important to report ADEs although reporting tools, such as the Med Safety App, were not well known. We recommend awareness campaigns on reporting processes because this could improve consumer reporting of ADEs in South Africa.

摘要

背景

消费者报告药品不良事件(ADEs)可加强与用药相关的风险监测、提高公众意识并增进对药品安全性的理解。本研究旨在探讨南非成年人对药品不良事件的认知、对报告的态度以及对自身在报告药品不良事件中所起作用的看法。

方法

我们开展了一项横断面分析研究,居住在南非的成年人完成了一份在线问卷。收集到的数据采用描述性统计和推断性统计进行分析。

结果

我们收到了350名参与者的回复。大多数参与者(86.2%,n = 302;N = 350)报告听说过药品不良事件,且大多数参与者(94.4%,n = 301;N = 319)表示报告药品不良事件很重要。药品安全应用程序并不广为人知(17.3%,n = 58;N = 336),而南非卫生产品监管局(SAHPRA)相对较为知名(77.4%,n = 260;N = 336)。医疗保健提供者仅向55.7%(n = 180;N = 323)的参与者介绍过药品不良事件,只有50.5%(n = 163;N = 323)的参与者向其医疗保健提供者询问过药品不良事件。与非医疗保健专业人员(非HCP)相比,医疗保健专业人员(HCP)对药品不良事件的认知显著更高(p < 0.001)。

结论

大多数参与者了解药品不良事件,并认同报告药品不良事件很重要,尽管诸如药品安全应用程序等报告工具并不广为人知。我们建议开展关于报告流程的宣传活动,因为这可能会改善南非消费者对药品不良事件的报告情况。

相似文献

1
Awareness and Attitudes Regarding Adverse Drug Events and Reporting in South Africa.南非对药物不良事件及报告的认知与态度
Ther Innov Regul Sci. 2025 May 13. doi: 10.1007/s43441-025-00795-x.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
4
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
5
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
6
Individual-level interventions to reduce personal exposure to outdoor air pollution and their effects on people with long-term respiratory conditions.个体层面的干预措施以减少个人接触室外空气污染及其对长期呼吸系统疾病患者的影响。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD013441. doi: 10.1002/14651858.CD013441.pub2.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
9
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
10
Effects of consumers and health providers working in partnership on health services planning, delivery and evaluation.消费者和医疗服务提供者合作对卫生服务规划、提供和评估的影响。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD013373. doi: 10.1002/14651858.CD013373.pub2.

本文引用的文献

1
Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.评估医疗保健专业人员在药物警戒和药物不良反应报告方面的知识、态度、实践和障碍:一项跨中心的横断面研究。
PLoS One. 2023 May 24;18(5):e0285811. doi: 10.1371/journal.pone.0285811. eCollection 2023.
2
The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®.南非药物不良反应报告的完整性:VigiBase®中的分析。
Afr J Prim Health Care Fam Med. 2023 Jan 18;15(1):e1-e9. doi: 10.4102/phcfm.v15i1.3659.
3
Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
在夸祖鲁-纳塔尔省埃特肯威尼都会区的 3 家公立卫生机构中,艾滋病毒感染者及其医生报告药物不良反应的认知、做法和障碍:一项横断面和回顾性分析。
BMC Health Serv Res. 2022 Aug 18;22(1):1054. doi: 10.1186/s12913-022-08395-3.
4
Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.在威尔士引入国家报告指标后,通过黄卡计划报告疑似药物不良反应的变化。
Br J Clin Pharmacol. 2022 Aug;88(8):3829-3836. doi: 10.1111/bcp.15326. Epub 2022 Apr 7.
5
Consumers' adverse drug event reporting via community pharmacists: three stakeholder perception.消费者通过社区药剂师报告药品不良事件:三方利益相关者的看法
J Pharm Policy Pract. 2022 Mar 14;15(1):19. doi: 10.1186/s40545-022-00417-z.
6
A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.一项横断面研究:比较中东部和中西部地区公众对药品不良反应报告和监测的认知。
BMC Health Serv Res. 2022 Mar 8;22(1):318. doi: 10.1186/s12913-022-07720-0.
7
Spontaneous reporting of adverse drug reaction among health professionals in Ghana.加纳卫生专业人员对药物不良反应的自发报告。
Arch Public Health. 2022 Jan 20;80(1):33. doi: 10.1186/s13690-021-00783-1.
8
Parental reporting of adverse drug reactions in South Africa: An online survey.南非的药物不良反应家长报告:一项在线调查。
Afr J Prim Health Care Fam Med. 2021 Sep 29;13(1):e1-e8. doi: 10.4102/phcfm.v13i1.2880.
9
Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania.立陶宛公众对药物不良反应看法的定性研究
Healthcare (Basel). 2021 Mar 9;9(3):303. doi: 10.3390/healthcare9030303.
10
Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.探索医疗保健专业人员对药物警戒的知识、态度和实践:一项横断面调查。
J Pharm Policy Pract. 2021 Jan 4;14(1):5. doi: 10.1186/s40545-020-00287-3.